No photo of Mary Eugenia Rinella

View Scopus Profile

Mary Eugenia Rinella

  • 3260 Citations
20012021
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Certifications and Licenses

Transplant Hepatology
Gastroenterology

Training Experience

1999Residency, University of Chicago Hospitals
2002Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Illinois - Chicago

… → 1996

Research interests

  • Colonoscopy
  • Esophagogastroduodenoscopy (EGD)
  • Hepatitis
  • Liver Biopsy
  • Liver/Hepatic Disease
  • Non-Alcoholic Fatty Liver Disease
  • Variceal Banding
  • Viral Hepatitis

Fingerprint Dive into the research topics where Mary Eugenia Rinella is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Fatty Liver Medicine & Life Sciences
Liver Medicine & Life Sciences
Liver Transplantation Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Non-alcoholic Fatty Liver Disease Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Diet Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2004 2021

Metabolic biomarkers as predictors of Nash recurrence after liver transplant

Rinella, M. E.

American College of Gastroenterology

7/1/19 → 6/30/20

Project: Research project

Biomarkers
Transplants
Recurrence
Liver
Lipids

Prot# EDP 305-101: A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects with Non-alcoholic Steatohepatitis (NASH)

Rinella, M. E.

ICON Clinical Research, LLC, Enanta Pharmaceuticals, Inc.

9/11/18 → 9/12/21

Project: Research project

Prot#GS-US-454-4378: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Subjects with Bridging (F3) Fibrosis or Compensated Cirrhosis (F4) due to Nonalcoho

Rinella, M. E.

PRA Health Sciences, Gilead Sciences, Inc.

8/23/18 → 8/23/21

Project: Research project

Study# CRAD001HUS191T: Post-transplant NASH protocol to assess the development of metabolic co-morbidities and disease recurrence in those transplanted for NASH cirrhosis (CRAD001HUS191T)

Rinella, M. E.

Novartis Pharmaceuticals Corporation

7/1/18 → 12/31/19

Project: Research project

Prot# 747-304: A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis

Rinella, M. E.

INC Research, LLC, Intercept Pharmaceuticals, Inc.

4/13/18 → 4/13/21

Project: Research project

Research Output 2001 2019

2 Citations (Scopus)

Atrial fibrillation is highly prevalent yet undertreated in patients with biopsy-proven nonalcoholic steatohepatitis

Whitsett, M., Wilcox, J. E., Yang, A., Zhao, L., Rinella, M. E. & VanWagner, L. B., May 1 2019, In : Liver International. 39, 5, p. 933-940 8 p.

Research output: Contribution to journal › Article

Atrial Fibrillation
Biopsy
International Classification of Diseases
Non-alcoholic Fatty Liver Disease
Cardiovascular Diseases

Editorial: sarcopenia in liver transplantation-our weakest patients may need the strongest push

Mazumder, N. & Rinella, M. E., Apr 1 2019, In : Alimentary pharmacology & therapeutics. 49, 8, p. 1100-1101 2 p.

Research output: Contribution to journal › Editorial

Open Access
Sarcopenia
Liver Transplantation

Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges

Samji, N. S., Verma, R., Keri, K. C., Singal, A. K., Ahmed, A., Rinella, M. E., Bernstein, D., Abdelmalek, M. F. & Satapathy, S. K., Jan 1 2019, In : Digestive diseases and sciences.

Research output: Contribution to journal › Review article

Liver Transplantation
Transplants
Recurrence
Liver
Obstructive Sleep Apnea

Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis

Lee, B. P., Samur, S., Dalgic, O. O., Bethea, E. D., Lucey, M. R., Weinberg, E., Hsu, C., Rinella, M. E., Im, G. Y., Fix, O. K., Therapondos, G., Han, H., Victor, D. W., Voigt, M. D., Eswaran, S., Terrault, N. A. & Chhatwal, J., Aug 1 2019, In : Gastroenterology. 157, 2, p. 472-480.e5

Research output: Contribution to journal › Article

Liver Transplantation
Hepatitis
Alcohols
Transplantation
Life Expectancy

Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients

Cheung, A., Figueredo, C. & Rinella, M. E., Apr 1 2019, In : The American journal of gastroenterology. 114, 4, p. 579-590 12 p.

Research output: Contribution to journal › Article

Disease Management
Liver Diseases
Fibrosis
Liver Transplantation
Non-alcoholic Fatty Liver Disease